Invivyd, Inc. (IVVD)
0.9274
-0.09
(-9.08%)
USD |
NASDAQ |
Sep 22, 12:05
Invivyd Price to Book Value : 1.510 for Sept. 22, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 21, 2026 | 1.660 |
| September 18, 2026 | 1.229 |
| September 17, 2026 | 1.215 |
| September 16, 2026 | 1.311 |
| September 15, 2026 | 1.351 |
| September 14, 2026 | 1.452 |
| September 11, 2026 | 1.279 |
| September 10, 2026 | 1.263 |
| September 09, 2026 | 1.298 |
| September 08, 2026 | 1.344 |
| September 04, 2026 | 1.344 |
| September 03, 2026 | 1.359 |
| September 02, 2026 | 1.309 |
| September 01, 2026 | 1.432 |
| August 31, 2026 | 1.554 |
| August 28, 2026 | 1.57 |
| August 27, 2026 | 1.465 |
| August 26, 2026 | 1.468 |
| August 25, 2026 | 1.528 |
| August 24, 2026 | 1.534 |
| August 21, 2026 | 1.622 |
| August 20, 2026 | 1.548 |
| August 19, 2026 | 1.562 |
| August 18, 2026 | 1.413 |
| August 17, 2026 | 1.205 |
| Date | Value |
|---|---|
| August 14, 2026 | 1.174 |
| August 13, 2026 | 1.116 |
| August 12, 2026 | 1.192 |
| August 11, 2026 | 1.119 |
| August 10, 2026 | 1.096 |
| August 07, 2026 | 1.204 |
| August 06, 2026 | 1.073 |
| August 05, 2026 | 0.9838 |
| August 04, 2026 | 0.933 |
| August 03, 2026 | 0.8979 |
| July 31, 2026 | 0.8709 |
| July 30, 2026 | 0.9467 |
| July 29, 2026 | 0.8839 |
| July 28, 2026 | 0.9658 |
| July 27, 2026 | 0.9928 |
| July 24, 2026 | 0.9952 |
| July 23, 2026 | 0.9916 |
| July 22, 2026 | 1.009 |
| July 21, 2026 | 1.110 |
| July 20, 2026 | 1.116 |
| July 17, 2026 | 1.209 |
| July 16, 2026 | 1.282 |
| July 15, 2026 | 1.330 |
| July 14, 2026 | 1.304 |
| July 13, 2026 | 1.282 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 18.78 |
| Anika Therapeutics, Inc. | 2.035 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.693 |
Price to Book Value Related Metrics
| PS Ratio | 4.299 |
| Price | 0.9274 |
| Earnings Yield | -40.22% |
| Market Cap | 273.36M |